Bio

Academic Appointments


  • Clinical Associate Professor, Pediatrics

Administrative Appointments


  • Associate Chief, Stanford School of Medicine Regional Pediatric Hospital Medicine Programs, Stanford School of Medicine (2017 - Present)
  • Chair, Council on Quality Improvement and Patient Safety (COQIPS) Committee on Guideline Development, American Academy of Pediatrics (2019 - Present)
  • Chair, Pediatric Hospital Medicine Club at Pediatric Academic Societies Conference, American Academy of Pediatrics (2019 - Present)
  • Co-Chair, Hospital Medicine Special Interest Group, Academic Pediatric Association (2019 - Present)
  • Co-Chair, Pediatric Hospital Medicine Leadership Special Interest Group, Academic Pediatric Association (2018 - Present)
  • Editor, Evidence-Based Clinical Practice Guidelines Development and Implementation Manual, American Academy of Pediatrics (2019 - Present)
  • Associate Editor, Common Clinical Diagnosis and Conditions, PHM Core Competencies, Society of Hospital Medicine (2017 - Present)
  • Co-Chair, COQIPS Guidelines, Evidence, and Transparency Committee, American Academy of Pediatrics (2016 - 2019)
  • Co-Chair, Pediatric Hospital Medicine Conference Awards Committee, AAP, APA, and SHM Joint Council (2016 - 2018)
  • Member, Maintenance of Certification (MOC) Portfolio Review Panel, American Academy of Pediatrics (2016 - 2018)
  • Member, Maintenance of Certification (MOC) Assessment Content Development Team, American Board of Pediatrics (2016 - 2017)
  • Regional Director, Pediatric Hospital Medicine Community Hospital Services, Children's National Medical Center (2015 - 2017)
  • Director, Children’s National Pediatric Hospital Medicine Program at Mary Washington Healthcare, Children's National Medical Center (2009 - 2015)
  • Medical Director, Short Stay Unit, Children's National Medical Center (2008 - 2009)

Boards, Advisory Committees, Professional Organizations


  • Member, Council on Quality Improvement and Patient Safety (COQIPS) Executive Committee, American Academy of Pediatrics (2019 - Present)
  • Member, Pediatric Hospital Medicine Choosing Wisely Committee, Society of Hospital Medicine (2018 - Present)
  • Member, Pediatrics Special Interest Group Executive Committee, Society of Hospital Medicine (2015 - Present)
  • Member, Academic Pediatric Association (2014 - Present)
  • Member, Society of Hospital Medicine (2010 - Present)
  • Member, American Academy of Pediatrics (2001 - Present)

Professional Education


  • Residency, Saint Christopher's Hospital for Children, Pediatrics (2003)
  • Medical Degree, MCP Hahnemann School of Medicine (2000)
  • Bachelor of Arts, University of Texas at Austin, Kinesiology (1996)

Publications

All Publications


  • The Value of Pediatricians on Pharmacy and Therapeutics Committees. P & T : a peer-reviewed journal for formulary management Austin, J. P., Gunden, S., Hoffner, W., Ismail, L., Mendez, S., Alvarez, F. 2019; 44 (1): 2–4

    View details for PubMedID 30675084

    View details for PubMedCentralID PMC6336204

  • Pediatric Medication Safety in Adult Community Hospital Settings: A Glimpse Into Nationwide Practice. Hospital pediatrics Alvarez, F., Ismail, L., Markowsky, A. 2016; 6 (12): 744–49

    Abstract

    Most children in the United States are treated in adult settings. Studies show that the pediatric population is vulnerable to medication errors. It can be extrapolated that children cared for in adult settings are at equal or higher risk for errors. The goal of this study was to assess the existing pediatric medication safety infrastructure within adult hospitals.Questionnaire developed through Research Electronic Data Capture (REDCap) and distributed to pediatric hospitalist programs listed on the American Academy of Pediatrics, Section on Hospital Medicine web site and members of the American Academy of Pediatrics Quality Improvement Innovation Networks listserv. There were >20 questions regarding the use of various safety measures and characteristics of the hospital.Thirty-eight program staff and 26 Quality Improvement Innovation Networks listserv members completed the survey (total = 64). Of these, 90.6% use order sets or computerized provider order entry with pediatric weight-based dosing, 79.7% review pediatric medication safety events or concerns, 58.7% were aware that their hospital had defined or documented maximum doses on orders, and 50.0% had milligram-per-kilogram dosing required to be in the order. A majority of respondents document weights only in the metric system (kilograms or grams) in both the emergency department and the pediatric unit (84.4% and 92.1%, respectively). A total of 57.8% of hospitals had pharmacists trained in pediatrics, with hospitals with >300 beds more likely to have a pediatric pharmacist than those with <300 beds (75% vs 44%, P ≤ .05).Pediatric medication safety infrastructure shows variations within the sites surveyed. Our results indicate that certain deficiencies are more widespread than others, providing opportunities for targeted, but hospital-specific interventions.

    View details for DOI 10.1542/hpeds.2016-0068

    View details for PubMedID 27811162

  • The Effect of Implementation of Standardized, Evidence-Based Order Sets on Efficiency and Quality Measures for Pediatric Respiratory Illnesses in a Community Hospital. Hospital pediatrics Dayal, A., Alvarez, F. 2015; 5 (12): 624–29

    Abstract

    Standardization of evidence-based care, resource utilization, and cost efficiency are commonly used metrics to measure inpatient clinical care delivery. The aim of our project was to evaluate the effect of pediatric respiratory order sets and an asthma pathway on the efficiency and quality measures of pediatric patients treated with respiratory illnesses in an adult community hospital setting.We used a pre-post study to review pediatric patients admitted to the inpatient setting with the primary diagnoses of asthma, bronchiolitis, or pneumonia. Patients with concomitant chronic respiratory illnesses were excluded. After implementation of order sets and asthma pathway, we examined changes in respiratory medication use, hospital utilization cost, length of stay (LOS), and 30-day readmission rate. Statistical significance was measured via 2-tailed t-test and Fisher test.After implementation of evidence-based order sets and asthma pathway, utilization of bronchodilators decreased and the hospital utilization cost of patients with asthma was reduced from $2010 per patient in 2009 to $1174 per patient in 2011 (P < .05). Asthma LOS decreased from 1.90 days to 1.45 days (P < .05), bronchiolitis LOS decreased from 2.37 days to 2.04 days (P < .05), and pneumonia LOS decreased from 2.3 days to 2.1 days (P = .083). Readmission rates were unchanged.The use of order sets and an asthma pathway was associated with a reduction in respiratory treatment use as well as hospitalization utilization costs. Statistically significant decrease in LOS was achieved within the asthma and bronchiolitis populations but not in the pneumonia population. No statistically significant effect was found on the 30-day readmission rates.

    View details for DOI 10.1542/hpeds.2015-0140

    View details for PubMedID 26596964

  • PHM16: How to Design, Improve Educational Programs at Community Hospitals Alvarez, F. The Hospitalist. 2016
  • PHM15: New Quality Measures for Children with Medical Complexity Alvarez, F. The Hospitalist. 2015
  • PHM15: A Closer Look at Quality Indicators, Evaluation Tools Alvarez, F. The Hospitalist. 2015
  • Albuterol MDI versus Nebulizer for Acute Asthma Exacerbation Alvarez, F. Hospital Pediatrics . Online Newsletter. 2008